CNR2 and rheumatoid arthritis: This adds another hint for the possible role of this system in RA pathogenesis and for the potential use of synthetic cannabinoids to target RA, especially that the immune-modulatory effects of these cannabinoids are mediated through cannabinoid receptors, mainly CB2 [63].